The level of markers of apoptosis and cell proliferation in the area of restenosis after lower extremity arterial reconstruction
- Authors: Kalinin RE1, Suchkov IA1, Klimentova EA2, Shchulkin AV1, Gerasimov AA2, Povarov VO1
-
Affiliations:
- Ryazan State Medical University
- Regional Clinical Hospital
- Issue: Vol 102, No 4 (2021)
- Pages: 453-458
- Section: Theoretical and clinical medicine
- URL: https://journal-vniispk.ru/kazanmedj/article/view/61187
- DOI: https://doi.org/10.17816/KMJ2021-453
- ID: 61187
Cite item
Abstract
Aim. To assess the number of markers of apoptosis and cell proliferation, as well as their relationships in the area of restenosis of arterial reconstructions.
Methods. The study included 14 patients with a diagnosis of “arteriosclerosis obliterans of the lower extremities. Post-thrombotic occlusion of femoropopliteal bypass”. All patients were males with stage III disease according to the Fontaine classification modified by A.V. Pokrovsky. The average age of the patients was 65±3.4 years. The mean disease duration was 9±2.5 months after the initial intervention. Intraoperative material — distal anastomosis of femoropopliteal bypass — was taken from patients during arterial reconstructions. As a control, we used arterial wall samples obtained at organ procurement from postmortem donors without arteriosclerosis obliterans of the lower extremities. The number of samples is 8. The site of their collection is the popliteal artery. After sampling, they were crushed, and a homogenate was prepared, followed by the determination of the amount of p53, PDGF BB, Bcl2, and Bax proteins using the enzyme immunoassay. Statistical analysis was performed using the Statistica 10.0 software. Group differences were assessed by using the Mann–Whitney test. Correlation coefficients were determined using the Spearman test. Data are presented as medians and interquartile ranges.
Results. In tissue samples of restenosis, the amount of p53 protein was 0.07 units/mg and was significantly reduced compared with the control samples — 0.14 units/mg (р=0,015). The amount of platelet-derived growth factor PDGF BB was 0.17 ng/mg (р=0.05), Bcl2 — 1.61 ng/mg (р=0.008), Bax — 6.0 ng/mg (р=0.25) in the restenosis area and was increased in comparison with the control samples (0.04 ng/mg, 0.9 ng/mg, 4.4 ng/mg, respectively). A relationship between p53 and platelet-derived growth factor BB (r=–0.724, p=0.002), platelet-derived growth factor BB and Bcl2 (r=0.672, p=0.003) was revealed in samples from restenosis tissue obtained during arterial reconstructions.
Conclusion. The decreased apoptosis, expressed in a low level of p53 protein, with an increased Bax/Bcl-2 ratio is associated with an increase in the proliferative response of vascular wall cells in the area of restenosis of arterial reconstruction.
Full Text
##article.viewOnOriginalSite##About the authors
R E Kalinin
Ryazan State Medical University
Email: klimentowa.emma@yandex.ru
Russian Federation, Ryazan, Russia
I A Suchkov
Ryazan State Medical University
Email: klimentowa.emma@yandex.ru
Russian Federation, Ryazan, Russia
E A Klimentova
Regional Clinical Hospital
Author for correspondence.
Email: klimentowa.emma@yandex.ru
Russian Federation, Ryazan, Russia
A V Shchulkin
Ryazan State Medical University
Email: klimentowa.emma@yandex.ru
Russian Federation, Ryazan, Russia
A A Gerasimov
Regional Clinical Hospital
Email: klimentowa.emma@yandex.ru
Russian Federation, Ryazan, Russia
V O Povarov
Ryazan State Medical University
Email: klimentowa.emma@yandex.ru
Russian Federation, Ryazan, Russia
References
- Zhu Z.R., He Q., Wu W.B., Chang G., Yao C., Zhao Y., Wang M., Wang S.M. MiR-140-3p is involved in in-stent restenosis by targeting C-Myb and BCL-2 in peripheral artery disease. J. Atheroscler. Thromb. 2018; 25 (11): 1168–1181. doi: 10.5551/jat.44024.
- Zhu H., Zhang Y. Life and death partners in post-PCI restenosis: Apoptosis, autophagy, and the cross-talk between them. Curr. Drug Targets. 2018; 19 (9): 1003–1008. doi: 10.2174/1389450117666160625072521.
- Kalinin R.E., Suchkov I.A., Klimentova E.A., Egorov A.A. To the question of the role of apoptosis in the development of atherosclerosis and restenosis of the reconstruction zone. Novosti khirurgii. 2020; 28 (4): 418–427. (In Russ.) doi: 10.18484/2305-0047.2020.4.418.
- Klimentova E.A., Suchkov I.A., Ego¬rov A.A., Kalinin R.E. Apoptosis and cell proliferation mar¬kers in inflammatory-fibroproliferative diseases of the vessel wall (review). Sovremennye tekhnologii v me¬ditsine. 2020; 12 (4): 119–128. (In Russ.) doi: 10.17691/stm2020.12.4.13.
- Banfalvi G. Methods to detect apoptotic cell death. Apoptosis. 2017; 22 (2): 306–323. doi: 10.1007/s10495-016-1333-3.
- Gross A., Katz S.G. Non-apoptotic functions of ¬BCL-2 family proteins. Cell Death Differ. 2017; 24 (8): 1348–1358. doi: 10.1038/cdd.2017.22.
- Kolovou V., Tsipis A., Mihas C., Katsiki N., Vartela V., Koutelou M., Manolopoulou D., Leondiadis E., Iakovou I., Mavrogieni S., Kolovou G. Tumor protein p53 (TP53) gene and left main coronary artery disease. Angiology. 2018; 69 (8): 730–735. doi: 10.1177/0003319718760075.
- Cao R.Y., Eves R., Jia L., Funk C.D., Jia Z., Mak A.S. Effects of p53-knockout in vascular smooth muscle cells on atherosclerosis in mice. PLoS One. 2017; 12 (3): e0175061. doi: 10.1371/journal.pone.0175061.
- Kale J., Osterlund E.J., Andrews D.W. BCL-2 family proteins: changing partners in the dance towards death. Cell Death Differ. 2018; 25 (1): 65–80. doi: 10.1038/cdd.2017.186.
- Igase M., Okura T., Kitami Y., Hiwada K. Apoptosis and Bcl-xs in the intimal thickening of balloon-injured carotid arteries. Clin. Sci. (Lond.). 1999; 96 (6): 605–612. PMID: 10334966.
- Chen S., Dong S., Li Z., Guo X., Zhang N., Yu B., Sun Y. Atorvastatin calcium inhibits PDGF-ββ-induced proliferation and migration of VSMCs through the G0/G1 cell cycle arrest and suppression of activated PDGFRβ-PI3K-Akt signaling cascade. Cell Physiol. Biochem. 2017; 44 (1): 215–228. doi: 10.1159/000484648.
- Aravani D., Foote K., Figg N., Finigan A., Uryga A., Clarke M., Bennett M. Cytokine regulation of apoptosis-¬induced apoptosis and apoptosis-induced cell proliferation in vascular smooth muscle cells. Apoptosis. 2020; 25 (9–10): 648–662. doi: 10.1007/s10495-020-01622-4.
- Yonemitsu Y., Kaneda Y., Tanaka S., Nakashima Y., Komori K., Sugimachi K., Sueishi K. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ. Res. 1998; 82 (2): 147–156. doi: 10.1161/01.res.82.2.147.
- George S.J., Angelini G.D., Capogrossi M.C., ¬Baker A.H. Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosis. Gene Ther. 2001; 8 (9): 668–676. doi: 10.1038/sj.gt.3301431.
- Bauriedel G., Hutter R., Schluckebier S., Welsch U., Prescott M.F., Kandolf R., Lüderitz B. Decreased apoptosis as a pathogenic factor in intimal hyperplasia of human arteriosclerosis lesions. Z. Kardiol. 1997; 86 (8): 572–580. doi: 10.1007/s003920050096.
- Scott S., O'Sullivan M., Hafizi S., Shapiro M., Bennett M.R. Human vascular smooth muscle cells from res¬tenosis or in-stent stenosis sites demonstrate enhanced responses to p53: implications for brachytherapy and drug treatment for restenosis. Circ. Res. 2002; 90 (4): 398–404. doi: 10.1161/hh0402.10590.
- Walsh K., Smith R.C., Kim H.S. Vascular cell apoptosis in remodeling, restenosis, and plaque rupture. Circ. Res. 2000; 87 (3): 184–188. doi: 10.1161/01.res.87.3.184.
Supplementary files
